Aquestive Therapeutics President and CEO Daniel Barber Reports Sale of $105,600 in Common Shares
Aquestive Therapeutics President, CEO and director Daniel Barber sold 25,000 shares of common stock on Oct. 15, 2026. The reported sale price was $4.224 per share. * Barber directly owned 627,317 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative art